Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q1 2024 Earnings

27FebConfirmed

Q2 2023

Q3 2023

Q4 2023

Q1 2024

-0.45

-0.2

0.04

0.29

Details

Expected EPS

0.29

Actual EPS

0.28

Surprise EPS

-0.01

Surprise Percent

+3.45%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of 0.28 per share for Q1 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.